RUBICON ADVISORS, LLC

Lobbying for DYNAVAX TECHNOLOGIES · Pharmaceuticals

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$75,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.